Skip to main content

Response Genetics Extends Pact with Taiho

NEW YORK (GenomeWeb News) – Response Genetics today said that it has extended an agreement with Taiho Pharmaceutical to provide testing and analysis services.

The Los Angeles-based molecular diagnostic firm will provide its services for molecular markers used in research diagnostics and the therapeutic treatment of cancer, it said, adding it will receive at least $950,000 for services provided during the extended period of Jan. 1 to Dec. 31, 2013.

Response and Tokyo-based Taiho first collaborated in 2001.

"Response Genetics has and continues to provide Taiho with a comprehensive portfolio of gene expression assays … and we believe that the testing services resulting from this collaboration will yield actionable results important to patient care," Response Genetics Chairman and CEO Thomas Bologna said in a statement.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.